PhD scholarship: Economic evaluation of paediatric interventions for respiratory failure
|Enrolment status||New students|
|Student type||Domestic students, International students|
|Level of study||Higher Degree by Research|
|Study area||Business and Economics, Health and Behavioural Sciences, Medicine|
|HDR funding type||Living stipend scholarship|
|Scholarship value||$28,092 per annum (2020 rate), indexed annually|
|Scholarship duration||Three years with the possibility of two 6-month extensions|
|Opening date||1 September 2020|
|Closing date||15 September 2020|
The student will join world class researchers from both the Child Health Research Centre, UQ, and the School of Economics/Centre for Business and Economics of Health, UQ. The HDR candidate will be supervised Professor Brenda Gannon.
The objective of this study is to determine the cost-effectiveness of interventions for respiratory failure across paediatric patients. Focusing on specific randomised controlled trials, the aims include establishing the cost-effectiveness of paediatric interventions for respiratory failure. The project will specifically determine the cost-effectiveness of Transnasal Humidified Rapid Insufflation Ventilatory Exchange in comparison with standard care, and the cost-effectiveness of nasal high flow therapy in comparison with standard oxygen therapy in paediatric patients. Using appropriate economic evaluations models from health economics, the project will provide estimates of cost-effectiveness. The project will investigate alternative models and parameters, focusing on the costing approach and use of administrative data.
For more information click "LINK TO ORIGINAL" below.